Morningside Ventures

NewAmsterdam Pharma raises €160m Series A funding co-led by Forbion, Morningside Ventures and Ascendant BioCapital

– NETHERLANDS, Naarden –  NewAmsterdam Pharma, a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases, today announced the completion of a €160M Series A funding round co-led by Forbion Capital Partners, Morningside Ventures, and Ascendant BioCapital alongside Kaiser Foundation Hospitals, BVF Partners L.P.,…

Gracell Biotechnologies raises $100m Series C funding to fund research and development and advance clinical programs

– CHINA, Shanghai –  Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced it has secured $100 million in a Series C funding round led by Wellington Management Company, OrbiMed, and Morningside Ventures, and joined by new investor Vivo Capital.…

Big Health adds Janke Dittmer and Isaac Cheng to Board along with raising $39m Series B financing co-led by Gilde Healthcare and Morningside Ventures

– USA, CA –  Big Health, the global leader in digital therapeutics dedicated to helping millions back to good mental health, today announced it has raised $39 million in a Series B financing, led by Gilde Healthcare and joined by co-lead Morningside Ventures alongside other existing investors Kaiser Permanente Ventures, Octopus Ventures and Samsung NEXT.…